1. Canada Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
NanoSphere Health Sciences Inc.

NanoSphere Health Sciences Inc.

NSHSF
NanoSphere Health Sciences Inc.US flagOther OTC
0.01
USD
- -
- -
98,642.00Market Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
0.01
0.04
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-86.93
-1.03
-0.25
-0.43
-18.02
-0.93
-0.65
-0.11
-0.05
-0.03
-0.02
0.03
-0.01
-0.01
Free Cash Flow per Basic Share
-22.33
-1.77
-0.1
-0.25
-2.29
-0.67
-0.21
-0.01
-0.01
-0.01
-0.01
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-256.99
-82.81
-27.97
-1.84
5.58
-0.02
-0.39
-0.49
-0.33
-0.25
-0.27
-0.25
-0.25
-0.25
Tangible Book Value per Share
-5.07
-0.63
-0.17
-0.28
6.69
0.17
-0.17
-0.27
-0.16
-0.13
-0.15
-0.12
-0.13
-0.13
Basic Weighted Avg Shares
- -
- -
1
1
1
5
5
5
7
10
10
10
10
10
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
-12,143.64
-1,487.41
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-6
- -
- -
-1
-10
-5
-3
-1
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
-11,918.13
-1,590.92
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
4
- -
-1
-1
-1
-1
-2
-1
-1
-1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
4
1
-1
-1
-1
-1
-2
-1
-1
-1
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-10.06
- -
3.03
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-117.09%
0.76%
11%
Free Cash Flow
72.71%
-9.66%
-36.03%
Net Income, GAAP
152.43%
-85.46%
-132.2%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.01
-0.01
- -
- -
-0.02
2024
- -
-0.01
- -
- -
0.03
2025
-0.01
- -
- -
- -
-0.01

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Michael Alexander Iverson
Sector
Healthcare
Industry
Biotechnology
Address
1090 West Georgia Street Vancouver BC Canada V6E 3V7
IPO Date
Oct 8, 2009
Website
nanospherehealth.com
Similar Companies
CureVac N.V. (5CV.DE)
Genor Biopharma Holdings Limited (6998.HK)
Axsome Therapeutics, Inc. (0HKF.L)
Verastem, Inc. (2VSA.F)
Mersana Therapeutics, Inc. (MRSN)
ADR120S, Inc. (3750.T)
Business
NanoSphere Health Sciences Inc. (NSHSF) is a Canada-based nano-biotechnology company that develops and commercializes the patented NanoSphere Delivery System, a nanotechnology platform enhancing bioavailability, solubility, stability, and absorption of biologically active compounds including cannabinoids, supplements, nutraceuticals, over-the-counter medications, nonsteroidal anti-inflammatory drugs, and nutraceuticals for the cannabis, pharmaceutical, animal health, cosmetics, and botanical industries; the system encapsulates ingredients into nanosized particles within a viscoelastic matrix, enabling non-invasive transdermal and other delivery methods that bypass first-pass metabolism and gastrointestinal challenges. NanoSphere markets cannabis products under the Evolve Formulas brand, featuring the clinically tested NanoSerum transdermal serum for pain relief available to recreational and medical customers in Colorado, and supports joint ventures, licensing arrangements, and custom formulations for partners in pain management, anti-inflammatory treatments, and neurological health applications. Founded in 2005 and headquartered at 1090 West Georgia Street, Suite 488, Vancouver, British Columbia, Canada V6E 3V7, the company operates primarily in the United States and Canada through its wholly owned U.S. subsidiary NanoSphere Health Sciences LLC in Greenwood Village, Colorado, targeting pharmaceutical producers, cannabis extract distributors, and animal health providers with scalable manufacturing setups. Recent developments include an annual general meeting scheduled for December 23, 2025, ongoing efforts to secure financing amid a working capital deficit as of June 30, 2025, and maintenance of its core nanotechnology platform without major reported acquisitions, partnerships, or product launches in the past 1-2 years.

Company News

APIChat

  • newsfilecorp.com

    CSE Bulletin: Consolidation - NanoSphere Health Sciences Inc. (NSHS)